Diagnostics & Research | Healthcare
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
Market Cap
256607272960
Current Price
629.2
52 Week Range
599.55 - 960.6
Previous Close
626.15
Open
625.0
Industry
Diagnostics & Research
Sector
Healthcare
Address
Biocon SEZ, Biocon Park, Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road, Bengaluru, 560099, India
Phone
+91-80689-18000
Fax
+91-80689-18808
Website
https://www.syngeneintl.com
Day Low
620.7
Day High
631.35
Dividend Yield
0.2
PE Ratio
50.988655
Earnings Per Share
12.34
Beta
0.153
EBITDA
9912000512
Book Value
117.43
EPS
10.8913
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Peter James Jonathan Bains | CEO & MD | 67 | 1957 |
Mr. Deepak Jain | Chief Financial Officer | - | - |
Dr. Jayashree Aiyar Ph.D. | Chief Scientific Officer | - | - |
Krishnan G | Head of Investor Relations | - | - |
Mr. Sandeep Nair | Head of Corporate Communications | - | - |
Mr. Andrew Webster | Chief Human Resources Officer | - | - |
Dr. Dhananjay Patankar | Head of Pharmaceutical & Biopharmaceutical Development | - | - |
Mr. Purushottam Shashikant Singnurkar | Head of Formulations Development | - | - |
Mr. Ajit Manocha | Head of IT | - | - |
Dr. Chetan Prakash Tamhankar | Head of Clinical Development & Stability Studies | - | - |
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Healthcare • Diagnostics & Research
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.